AA

Advance Agrolife Ltd

Q3 FY26

Advance Agrolife Q3 FY26 investor presentation: Revenue & Margins

Q3 FY26 investor presentation: what the company reported on revenue, margins and projects.

Price₹158
Market cap₹1.0K Cr
P/E20.8
Updated16 Oct 2026
Read4 min read

Based on Advance Agrolife Ltd's Q3 FY26 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentationreports, not management guidance.

The short version

Q3 FY26 revenue from operations was ₹1,338 million, up 18% year-on-year (YoY) from ₹1,134 million in Q3 FY25 (Pages 23-24). Q3 FY26 EBITDA: ₹73.5 million, up 16% YoY - Q3 FY26 EBITDA margin: 5.5%, down slightly from 5.6% YoY - Q3 FY26 PAT: ₹30.1 million, up 8% YoY - For 9MFY26: - EBITDA: ₹502.5 million, up 20% YoY - EBITDA margin: 9.8%, slightly lower than 10.1% YoY - PAT: ₹278.2 million, up 15% YoY - Operating margin (OPM %) for FY25 and FY26 stands around 9% for annual figures.

From Advance Agrolife Ltd's Q3 FY26 earnings-call transcript · updated 16 Oct 2026.

Revenue & Sales Performance

  • Q3 FY26 revenue from operations was ₹1,338 million, up 18% year-on-year (YoY) from ₹1,134 million in Q3 FY25 (Pages 23-24).
  • Total income for Q3 FY26 was ₹1,338 million, marking an 18% YoY increase (Page 23).
  • For the 9 months ended December 31, 2025 (9MFY26), revenue was ₹5,153.9 million, a 25% YoY rise from ₹4,127.8 million in 9MFY25 (Pages 23-24).
  • Q3 FY26 EBITDA margin was 5.5%, with a 16% YoY EBITDA increase (Page 24).
  • Outlook: The company aims to grow volume through capacity expansions, particularly a 4x scale-up in 2,4-D herbicides (Page 20).

2 more points from Advance Agrolife Ltd's call on revenue

Pro opens every point from 15K+ earnings calls

Profitability & Margins

See what Advance Agrolife Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • 2,4-D Herbicides Capacity Expansion:
  • 4x scale-up planned, increasing production to 10,000 MT by Q4 FY28.
  • Aimed at addressing structural domestic deficits and enabling market penetration.
  • Potential new location: Dahej PCPIR chemical cluster for reduced raw material costs and logistical benefits.
  • Status: Execution ongoing, leveraging economies of scale and proximity advantages.
  • Backward Integration at Unit IV:
  • Transition from net buyer to manufacturer of technicals for fungicides/herbicides.
  • Targeting 25-30% reduction in COGS for specific products.
  • Status: Phase 2 in progress, replicating Unit I success.
  • Unit I Conversion:
  • Completed Proof of Concept converting Unit I to manufacture herbicide/insecticide/fungicide technicals.

2 more points from Advance Agrolife Ltd's call on capex

Pro opens every point from 15K+ earnings calls

Fundraising & Capital Structure

See what Advance Agrolife Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The investor presentation does not explicitly report any figures or details related to order book, order inflow, or pending orders. - There is no mention of order book size, order inflow, or backlog figures in the slides provided. - The presentation primarily focuses on financial performance, shareholding structure, strategic initiatives, capacity expansion, product portfolio, and operational highlights.

2 more points from Advance Agrolife Ltd's call on order book

Pro opens every point from 15K+ earnings calls

Advance Agrolife Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹124 Cr, net profit ₹7 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

What Advance Agrolife Ltd's management said in earlier quarters

Others in Fertilizers & Agrochemicals this season

  • Bhagiradha Chemicals & Industries Ltd (Q3 FY26)

    114.0 crore, up 11% YoY from Rs. Key investor presentation takeaways from Bhagiradha Chemicals & Industries Ltd's Q3 FY26 investor presentation — and how it ran

  • Sumitomo Chemical India Ltd (Q3 FY26)

    568.0 crore, down 12% year-on-year from Rs. Key concall takeaways from Sumitomo Chemical India Ltd's Q3 FY26 earnings call — and how it ranks against sector…

  • Indogulf Cropsciences Ltd (Q3 FY26)

    The value of these export orders in hand is approximately INR 4 to 5 crores. Key concall takeaways from Indogulf Cropsci's Q3 FY26 earnings call — and how it…

  • Sharda Cropchem Ltd (Q3 FY26)

    Capex planned in the range of INR 450-500 crores to support growth and registration activities. Key concall takeaways from Sharda Cropchem Ltd's Q3 FY26…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Advance Agrolife Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Advance Agrolife Ltd Q3 FY26 results?

Q3 FY26 revenue from operations was ₹1,338 million, up 18% year-on-year (YoY) from ₹1,134 million in Q3 FY25 (Pages 23-24). Q3 FY26 EBITDA: ₹73.5 million, up 16% YoY - Q3 FY26 EBITDA margin: 5.5%, down slightly from 5.6% YoY - Q3 FY26 PAT: ₹30.1 million, up 8% YoY - For 9MFY26: - EBITDA: ₹502.5 million, up 20% YoY - EBITDA margin: 9.8%, slightly lower than 10.1% YoY - PAT: ₹278.2 million, up 15% YoY - Operating margin (OPM %) for FY25 and FY26 stands around 9% for annual figures.

What is Advance Agrolife Ltd share price analysis?

Advance Agrolife Ltd currently shows a neutral. The stock trades at a P/E of 20.8 with a market cap of ₹1,016 Cr. Investors should review the full earnings analysis for detailed insights.

Is Advance Agrolife Ltd planning capital expenditure?

2,4-D Herbicides Capacity Expansion: - 4x scale-up planned, increasing production to 10,000 MT by Q4 FY28.

Keep Advance Agrolife Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.